Amy Crawford-Faucher, MD, vice chair of the Primary Care Institute and Department of Family Medicine at Allegheny Health Network, discussed recent reports from the World Health Organization about COVID-19.
Amy Crawford-Faucher, MD, vice chair of the Primary Care Institute and Department of Family Medicine at Allegheny Health Network, discussed recent new World Health Organization research on vaccine protection against COVID-19.
Transcript
A report from the World Health Organization found that people are having long-lasting protection against COVID-19 when they have been both vaccinated and infected up to 12 months after infection. How do you think that changes how COVID-19 is addressed by the primary care physician for both adults and children?
So I think that, clearly, the COVID situation has been evolving now for 3 years. And so that kind of fits our anecdotal evidence that if you had all the vaccines and the COVID infection that you seem pretty well protected. And if you get COVID again it tends to be mild. I certainly have patients who've gotten COVID, 3 times so far, and they're fully immunized and then folks who still haven't gotten it at all. So I do think, because so much of the population has had a COVID infection, that if we can maintain our COVID vaccination rates and booster rates, that if this evidence continues to bear out, I think that's really exciting, because I think that's how we get to a level of herd immunity that can make COVID eventually look more like flu. And could help kind of add credence to, you get your flu shot once a year, you get your COVID shot once a year.
Insurance Payer Is Associated With Length of Stay After Traumatic Brain Injury
February 21st 2025Among hospitalized patients with traumatic brain injury, Medicaid fee-for-service was associated with longer hospital stays than private insurance and Medicaid managed care organizations.
Read More
NSCLC Advancements Offer Hope, but Disparities Persist
February 20th 2025Ioana Bonta, MD, Georgia Cancer Specialists, discusses the evolving state of non-small cell lung cancer (NSCLC) treatments, their impact on patient outcomes, and the need to address ongoing disparities in these populations.
Read More
Politics vs Science: The Future of US Public Health
February 4th 2025On this episode of Managed Care Cast, we speak with Perry N. Halkitis, PhD, MS, MPH, dean of the Rutgers School of Public Health, on the public health implications of the US withdrawal from the World Health Organization and the role of public health leaders in advocating for science and health.
Listen
Adapting ACA Access Amid Medicaid Transition and Policy Reversals: Molly Dean
February 19th 2025As enrollment shifts to the Affordable Care Act (ACA) marketplace following the unwinding of Medicaid and the Trump administration begins to implement health policy changes, Molly Dean, MSW, Siftwell's policy advisor, shares insight on how to adapt.
Read More